Outsourcing Pharma

MARCH 14, 2022

The pharma company and academic institution will explore the viability of a psychedelic treatment to help patients suffering from cancer-related distress.

Pharma Companies 122

Pharma Companies Clinical Development Development 122

Outsourcing Pharma

OCTOBER 24, 2023

Clinical stage pharma company PharmaKure believe their combined drug targeting amyloid deposits associated with Alzheimerâs Disease can bring quality of life to patients.

Pharma Companies 52

Pharma Companies Trials Drugs Clinical Development 52

Outsourcing Pharma

OCTOBER 24, 2023

Clinical stage pharma company PharmaKure believe their combined drug targeting amyloid deposits associated with Alzheimerâs Disease can bring quality of life to patients.

Pharma Companies 52

Pharma Companies Drugs Clinical Development Development 52

pharmaphorum

APRIL 19, 2021

“If you look at the development, we signed 15,000 people in six weeks in a trial set up by the NHS. It spotlighted the UK as a place to do clinical development.”. Speed is everything in clinical development. It is really important and we have seen a lot of pharma companies interested in the UK.

Vaccination 141

Vaccination Vaccine Manufacturing Clinical Development 141

pharmaphorum

JULY 8, 2022

The number of AI-based drug discovery strategic alliances has increased significantly, from just 10 in 2015 to 105 in 2021, with companies like BenevolentAI, Exscientia and Insilico Medicine featuring prominently in the dealmaking. billion, according to the report.

Drugs 131

Drugs Clinical Development Marketing Genome 131

Outsourcing Pharma

OCTOBER 6, 2022

The Danish company becomes the latest large pharma company to invest in NLRP3 assets, with these types of treatments holding the potential to treat a variety of diseases linked to inflammation.

Pharma Companies 78

Pharma Companies Clinical Development Development 78

Outsourcing Pharma

OCTOBER 6, 2022

is the first startup to emerge from the alliance of pharma companies and investors that created AION Labs, and will focus on improving the efficacy and safety of drug candidates.

Pharma Companies 72

Pharma Companies Drugs Clinical Development Development 72

pharmaphorum

JUNE 1, 2022

Astellas has become the latest big pharma company to sink some money into immuno-oncology start-up GO Therapeutics, forging an alliance to develop antibodies targeting two glycoprotein targets. The Japanese drugmaker is paying $20.5 The post Astellas taps GO’s glycoprotein platform with $783.5m deal appeared first on.

Gene Therapy 98

Gene Therapy Clinical Development Antibody Gene 98

Outsourcing Pharma

FEBRUARY 7, 2023

The pharma company provides funding to 24 community organizations throughout the US, as part of its newly created âToward Health Equity Oncology Grantâ.

Pharma Companies 52

Pharma Companies Clinical Development Development 52

Outsourcing Pharma

NOVEMBER 15, 2021

The pharma company has completed enrollment of amyotrophic lateral sclerosis patients in its study investigating drugs like verdiperstat, an oral treatment.

Clinical Trials 69

Clinical Trials Clinical Trials Pharma Companies Trials 69

BioPharma Reporter

NOVEMBER 3, 2022

Purdue University and the pharma company will create a scholarship program and renew their strategic research collaboration as part of the agreement.

Manufacturing 52

Manufacturing Pharma Companies Research Clinical Development 52

pharmaphorum

APRIL 12, 2022

Separating the amount of antibiotic used from the payment model could entice pharma companies – who have abandoned antimicrobial R&D in their drives in the last decades – to enter the category once again and help to develop new drugs that will tackle the pressing issue of antimicrobial resistance (AMR).

Pharma Companies 119

Pharma Companies Development Drugs Medicine 119

pharmaphorum

OCTOBER 15, 2021

Pharma companies are embracing patient centricity in drug development more than ever before. Over the last decade, leaders in the industry have championed patient engagement, putting it at the heart of commercial strategies. I don’t want to be called a patient, and I’m not on a journey.”. “I

Pharma Companies 40

Pharma Companies Clinical Development Medicine Development 40

XTalks

OCTOBER 4, 2023

In the specialized, personalized and advanced medicines spaces, this work should start very early — as early as Phase I or Phase II of clinical development. In the specialized, personalized and advanced medicines spaces, this work should start very early — as early as Phase I or Phase II of clinical development.

Marketing 105

Marketing Development Drugs Gene Therapy 105

Drug Discovery World

OCTOBER 18, 2022

The CoI currently has 25 members from Japan, US, and Europe, including top 10 pharma companies, CROs, and academic representatives. The group are now calling for all those interested – including research organisations, investigators, pharma companies, and patient groups – to get involved.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Life Science 52

pharmaphorum

SEPTEMBER 3, 2020

King’s Cross is also home to Google’s DeepMind artificial intelligence company, which has already been involved in life sciences projects such as using the technology to predict acute kidney injury.

Life Science 114

Life Science Engineer Scientist Pharma Companies 114

Outsourcing Pharma

JULY 27, 2020

Elucid Digital Healthâs Pill Connect is designed to enable CROs and pharma companies to monitor patient adherence during a clinical trial.

Pharma Companies 52

Pharma Companies Clinical Trials Clinical Trials Drugs 52

pharmaphorum

FEBRUARY 26, 2021

UCB and Microsoft have announced a multi-year strategic collaboration to advance the digitalisation of the Belgian pharma company and accelerate its research efforts. The companies have already been working together on the COVID Moonshot Project, which aimed to create an orally available antiviral to combat the SARS-CoV-2 coronavirus.

Drugs 92

Drugs Medicine Pharma Companies Clinical Development 92

pharmaphorum

APRIL 22, 2021

Biosensor firm physIQ has licensed its technology to Johnson & Johnson’s Janssen pharma unit in a multi-year deal, to investigate use of wearable sensors in virtual clinical trials. The pharma company will use the technology known as accelerateIQ to collect data across its clinical studies through a variety of wearable biosensors.

Licensing 72

Licensing Licensing Trials Clinical Trials 72

pharmaphorum

JULY 7, 2022

As this issue’s contributors discuss, by working together pharma companies and healthcare providers can significantly enhance oncology treatment for patients. Therapeutic cancer vaccine trials have an opportunity to leverage recent interest in vaccine technology to make headway in oncology, says Advanced Clinical’s Christopher Oelkrug.

Vaccination 52

Vaccination Vaccine Life Science Trials 52

pharmaphorum

DECEMBER 21, 2021

Novartis has joined the ranks of big pharma companies developing TIGIT-targeted drugs for cancer, and found its candidate in an existing partner, Chinese biotech BeiGene. Pharma companies are looking at whether blocking TIGIT as well as PD-1/PD-L1 can improve the efficacy of cancer immunotherapy.

Drugs 98

Drugs Antibody Pharma Companies Development 98

pharmaphorum

JANUARY 24, 2022

Francisco Partners is picking up a range of databases and analytics tools – including Health Insights, MarketScan, Clinical Development, Social Programme Management, Micromedex and other imaging and radiology tools – for an undisclosed sum estimated to be in the region of $1 billion.

Radiology 111

Radiology Marketing Genome Genomics 111

pharmaphorum

DECEMBER 22, 2021

Gyroscope Therapeutics and its gene therapy for the sight-robbing disease geographic atrophy (GA) has been acquired by a big pharma company – but likely not the one you would expect.

Gene Therapy 105

Gene Therapy Gene Licensing Licensing 105

pharmaphorum

NOVEMBER 11, 2022

” Most large pharma companies have also ramped up public commitments to close clinical trial diversity gaps, says the report, including operational measures like inclusive early trial planning, diversity metric tracking, selection of sites, and execution of study participant recruitment programmes.

Clinical Trials 96

Clinical Trials Clinical Trials Trials Pharma Companies 96

XTalks

MARCH 28, 2024

The FDA’s approval of Duvyzat for DMD, based on our robust and successful clinical development program, reflects Italfarmaco’s commitment to providing a safe and proven-effective therapy that can have a meaningful impact for people living with DMD,” said Paolo Bettica, MD, PhD, chief medical officer at Italfarmaco Group in a press release.

FDA Approval 105

FDA Approval Genetics Gene Therapy Gene 105

pharmaphorum

JULY 1, 2021

Merck and its partners are hoping to have initial data from trials of the bioelectronic device by the end of 2022 , which will then be used to establish a clinical development plan with an eye on getting approvals in major markets like Europe and the US.

Drug Delivery 94

Drug Delivery Pharma Companies Clinical Development Development 94

pharmaphorum

MAY 3, 2022

The new drug – Quviviq (daridorexant) – has been approved by the European Commission for adults who have been suffering insomnia for at least three months and are experiencing “considerable impact” on daytime functioning, according to the Swiss pharma company.

Marketing 97

Marketing Drugs Sales Pharma Companies 97

pharmaphorum

DECEMBER 15, 2021

Dialogue requires humility on the drug company’s side—accepting that sometimes we are wrong about matters we think we understand—and trust on the patients’ side that representatives of large, for-profit entities really have come to listen. Previously, Anthony served as the Global Head of Patient Insights, Solutions and Outcomes at Sanofi.

Pharma Companies 145

Pharma Companies Development Medicine Clinical Trials 145

pharmaphorum

MAY 4, 2022

In testing new treatments, what is promising in animal models may not transfer particularly well to humans, which helps to explain why there is a 90% failure rate during clinical development. Once selected, Quris can in-license them, progress them through to phase 1 trials and, those that succeed, can be licensed to pharma companies.

Drugs 143

Drugs Licensing Licensing Pharma Companies 143

The Pharma Data

JANUARY 4, 2021

Rothenberg did not provide any information as to what his next role may be – whether he will take over the helm of a pharma company or assume a role on one or more boards of directors. I have every confidence in her continued success in this new role,” Rothenberg said.

HR 52

HR Clinical Development Scientist Pharma Companies 52

pharmaphorum

JULY 6, 2022

A Franco-German joint venture company – Aurobac Therapeutics – has been formed to try to tackle the rising threat of antimicrobial resistant (AMR) infections. Evotec will contribute its research expertise, with a 200-strong team of scientists working in this area.

In-Vitro 59

In-Vitro Development Pharma Companies Drugs 59

pharmaphorum

APRIL 28, 2022

Although they have, by definition, small addressable markets, the treatments cost just as many resources to develop as therapies for more common diseases – sometimes more, because of the added difficulty of finding sufficiently large patient populations for trials and finding disease experts to run them. How big pharma tackles rare diseases.

Pharma Companies 59

Pharma Companies Branding Development Marketing 59

Delveinsight

AUGUST 2, 2020

The company has also signed a licensing agreement with Ono Pharmaceutical , a Japanese pharma company, transferring exclusive rights to develop and commercialise anamorelin in Japan, South Korea, and Taiwan. Cancer Cachexia Pipeline.

Marketing 94

Marketing Pharma Companies Development Hormones 94

pharmaphorum

JULY 5, 2021

Parexel’s chief executive Jamie Macdonald said that in the past 18 months, the company “has continued its strong growth trajectory” in a market for outsourced clinical services that at conservative estimates is expected to grow at a rate of 8% to 9% in the coming years.

Clinical Trials 64

Clinical Trials Clinical Trials Regulation Trials 64

pharmaphorum

JUNE 16, 2021

California biotech Ambrx Biopharma is hoping to raise $126 million from a listing on the New York Stock Exchange (NYSE) that will be used in part to fund clinical development of ARX-788, its HER2-targeting antibody drug conjugate (ADC). The company plans to list on the NYSE with the AMAM ticker.

Sales 55

Sales Antibody Drugs Pharma Companies 55

pharmaphorum

MARCH 2, 2022

The pharma company was quick to point out however that the CLOVER trial of PF-06425090 was undermined by a lower-than expected rate of C. diff since Sanofi ended development of its candidate in 2017, ahead of Valneva whose VLA84 has been shelved after phase 2 while it looks for a development partner.

Vaccination 52

Vaccination Vaccine Trials Bacterium 52

XTalks

OCTOBER 22, 2020

However, during the last months, due to COVID-19, we have observed how pharmaceutical companies have progressed very quickly through all the clinical development phases and different companies have already reached the clinical Phase III.

Manufacturing 98

Manufacturing Development Production Gene Therapy 98